Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

SWITZERLAND: Pyridomycin Turns Out to Be a Lethal Weapon Against TB (12.04.2013) Aids Weekly Plus

Medical Science News reports that pyridomycin, a natural antibiotic produced by non-pathogenic soil bacteria, could be very effective in fighting TB. Researchers at École Polytechnique Fédérale de Lausanne (EPFL), the Swiss Federal Institute of Technology of Lausanne’s Global Health Institute, discovered pyridomycin’s effect on TB in 2012. The antibiotic inhibited the action of the “InhA” enzyme, an important enzyme for the TB bacterium. TB bacterium needs the InhA enzyme as well as a cofactor to create the cell membrane. Pyridomycin binds with the cofactor and neutralizes it. Pyridomycin also blocks the InhA binding site, which is another element the bacterium uses for forming the membrane. Pyridomycin’s inhibition of the InhA enzyme causes the bacterium’s membrane to burst. The dual action reduces the possibility of TB resistance, since two mutations must exist simultaneously to develop resistance. According to the research, pyridomycin binds effectively to the molecules; however, it cannot be used therapeutically yet, because it would not last long enough in the patient’s body. Researchers are working on developing a more robust version of the molecule. Stewart Cole, director of the Global Health Institute and leader of the research, believes that eventually they could multiply the binding sites and inhibit critical functions of other pathogenic bacteria. The full report, “Pyridomycin Bridges the NADH- and Substrate-Binding Pockets of the Enoyl reductase InhA,” was published online in the journal Nature Chemical Biology (2013; doi:10.1038/nchembio.1405).


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in December 16, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.